PURPOSE: Although the slow healing rate of @entity3179 is well known, the underlying defect in the healing process is not well understood. The purpose of this study was to examine the cellular characteristics of fibroblasts taken from @entity3179 (wound-fb) and compare them with the fibroblasts of normal tissue (normal-fb). METHODS: Biopsy specimens were obtained from wound margins and normal tissue of the upper thigh in each @entity1 . Dermal fibroblasts were isolated from explant cultures in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. These cells were then plated at 1000 cells per plate, and total cells per plate were counted over time so that growth curves could be generated. In further experimentation, media was supplemented with additional calf serum (20%, 30%, 40%, 50%) and growth factors ( @entity4179 , basic fibroblast growth factor, @entity1356 ) in an attempt to stimulate growth. RESULTS: Two major differences were noted: (1) normal-fb replicated more rapidly than wound-fb; and (2) the morphologic features of wound-fb were different. Normal-fb were compact and tapered, with well-defined nuclear morphologic features. Wound-fb were larger and polygonal in shape, with less-uniform nuclear morphologic features. Additional calf serum in tissue culture media enhanced normal-fb growth but had no effect on wound-fb. Supplementation of media with growth factors stimulated the growth of wound-fb. Statistically significant differences were noted at day 10 and 14 with basic fibroblast growth factor supplementation (p = 0.02 and 0.0001, respectively) and at day 14 with @entity4179 (p = 0.008). Although @entity1356 stimulated cell growth in five of six @entity1 , the differences observed were not statistically significant. CONCLUSIONS: Our data demonstrate that wound-fb proliferate at a slower rate and are morphologically distinct from normal-fb. These characteristics are typical of aged or senescent cells. This decreased growth can be stimulated by growth factors basic fibroblast growth factor, @entity4179 , and @entity1356 . Slowed growth may be partially responsible for the defect in healing of @entity3179 . Furthermore, we believe that in some @entity1 @entity1066 may be improved by exogenous provision of specific growth factors.

Reduced growth of dermal fibroblasts from chronic XXXX can be stimulated with growth factors.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1356 :: ('3553', 'Gene') :: ['interleukin-1 beta'] @entity1066 :: ('MESH:D014456', 'Disease') :: ['ulcer healing'] @entity3179 :: ('MESH:D014647', 'Disease') :: ['venous ulcers', 'venous stasis ulcers'] @entity4179 :: ('1950', 'Gene') :: ['epidermal growth factor']
@entity3179 :: (MESH:D014647,Disease) :: ['venous ulcers']
